Immune cells called Natural Killer (NK) cells accumulate in tumors and release chemicals that attract specialized dendritic cells (cDC1) which are white blood cells known for triggering anti-cancer immune responses - to the tumor, according to recent research at the Francis Crick Institute.
These findings could help develop better immunotherapies for cancer.
Soft Tissue Sarcoma
Soft tissue sarcoma is a rare cancer of connective tissue that can affect soft tissues such as fat, muscle, nerves and blood vessels of any body part.
Advertisement
‘Natural Killer (NK) cells attract immune cells to cancerous tumors. Availability of these NK cells in the tumor environment shape tumor development and anti-cancer immunity and may help develop better cancer immunotherapies.’
Tweet it Now
Genes associated with Natural Killer cells and cDC1 correlated with cancer patient survival in a dataset of over 2,500 patients with skin, breast, neck and lung cancers. A similar correlation was seen in an independent group of breast cancer patients, with a particularly positive outcome for women with triple-negative breast cancer, which typically has a poor prognosis.
"Our findings have given us a renewed appreciation of the importance of Natural Killer cells and cDC1 in the immune response against cancer," says Professor Caetano Reis e Sousa, Senior Group Leader at the Crick, who led the study. "It's still early days, but attracting more cDC1 to tumors could be the basis of a new immunotherapy for cancer patients."
![Breast Cancer]( "Breast Cancer")
Breast cancer is a cancer that affects the breasts or mammary glands. Early detection and lifestyle changes help in controlling breast cancer.
The team also showed that prostaglandin E2 (PGE2), a molecule produced by some cancer cells, suppresses Natural Killer cell activity and reduces the responsiveness of cDC1 to the chemical attractants. This suggests that blocking PGE2 with aspirin might help boost the effectiveness of immunotherapies by restoring cDC1 levels in tumors.
"Now that we know a bit better how this key anti-cancer response works, we can look at identifying other ways in which cancers get around it," says Caetano. "This understanding will ultimately help us to develop new immunotherapy approaches to help more patients."
Professor Karen Vousden, Cancer Research UK's chief scientist, said: "This interesting research reveals more about the way the body's immune system interacts with cancer, exposing one way in which cancer can avoid attack.
"Studies like this highlight the complexity of this relationship and may reveal another way in which the immune system can be harnessed to treat cancer. It's vital that work continues to help make immunotherapies more effective and beneficial to more patients."
Source: Eurekalert
Breast Cancer
Breast cancer is a cancer that affects the breasts or mammary glands. Early detection and lifestyle changes help in controlling breast cancer.
Advertisement
The team also showed that prostaglandin E2 (PGE2), a molecule produced by some cancer cells, suppresses Natural Killer cell activity and reduces the responsiveness of cDC1 to the chemical attractants. This suggests that blocking PGE2 with aspirin might help boost the effectiveness of immunotherapies by restoring cDC1 levels in tumors.
"Now that we know a bit better how this key anti-cancer response works, we can look at identifying other ways in which cancers get around it," says Caetano. "This understanding will ultimately help us to develop new immunotherapy approaches to help more patients."
Professor Karen Vousden, Cancer Research UK's chief scientist, said: "This interesting research reveals more about the way the body's immune system interacts with cancer, exposing one way in which cancer can avoid attack.
"Studies like this highlight the complexity of this relationship and may reveal another way in which the immune system can be harnessed to treat cancer. It's vital that work continues to help make immunotherapies more effective and beneficial to more patients."
Source: Eurekalert
Breast Cancer Management: Advances
The crab that invades the breast is no more a fear factor with all the advancements that medical science and customized protocols can fight breast cancer. the recent developments in the management of breast cancer.
Advertisement
 Proton Beam Therapy for Cancer TreatmentProton therapy is a form of radiotherapy for cancer treatment which uses a proton beam that is targeted precisely on the tumor cells, destroying them with minimal damage to surrounding healthy tissue. Proton therapy can treat various types of cancer. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
More affected relatives, higher lung cancer risk; participants with affected mothers or siblings faced increased risk.
Colorectal cancer can be lowered by up to 7% by increasing dietary consumption of folate rich foods like spinach, broccoli or taking folate supplements.
The effects and mechanisms of microRNA-451a (miR-451a), which hinders the progression of gemcitabine-resistant biliary tract cancers, are under study.
The blood test pinpointed 13 proteins capable of distinguishing between early and late stages of pancreatic cancer.
A fatty acid present in dairy products, beef, and lamb called trans-vaccenic acid enhances immune cells' capacity to combat cancers.